The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 3 of the 173 sources its claims cite were checked for support.
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Open accessAbstract
The significance of polymicrobial infections is increasingly being recognized especially in a biofilm context wherein multiple bacterial species – including both potential pathogens and members of the commensal flora – communicate, cooperate and compete with each other. Two important bacterial pathogens that have developed a complex network of evasion, counter-inhibition and subjugation in their battle for space and nutrients are Pseudomonas aeruginosa and Staphylococcus aureus. Their strain- and environment-specific interactions, for instance in the cystic fibrosis lung or in wound infections, show severe competition that is generally linked to worse patient outcomes. For instance, the extracellular factors secreted by P. aeruginosa have been shown to subjugate S. aureus to persist as small colony variants. On the other hand, data also exist where S. aureus inhibits biofilm formation by P. aeruginosa but also protects the pathogen by inhibiting its phagocytosis. Interestingly, such interspecies interactions differ between the planktonic and biofilm phenotype, with the extracellular matrix components of the latter likely being a key, and largely underexplored, influence.This review attempts to understand the complex relationship between P. aeruginosa and Staphylococcus spp., focusing on S. aureus, that not only is interesting from the bacterial evolution point of view, but also has important consequences for our understanding of the disease pathogenesis for better patient management.
Overview
CoChat Summary
TL;DR
This review synthesizes in vivo and in vitro evidence on interactions between Pseudomonas aeruginosa and Staphylococcus spp., focusing on S. aureus, in biofilm and planktonic contexts. It describes a balance between P. aeruginosa antagonism—often via quorum-sensing-regulated factors such as HQNO, pyocyanin, LasA, rhamnolipids, and AHLs—and S. aureus survival strategies including SCV formation, SpA binding, and quorum quenching, with co-infection generally linked to worse outcomes.
Key findings
- Co-occurrence of P. aeruginosa and S. aureus in CF and chronic wounds is linked to worse outcomes: additive disease severity and increased lung inflammation/damage; MRSA is associated with worse lung function only in combination with P. aeruginosa. In a rabbit ear wound model, mixed infection increased IL-1β and TNF-α and reached equilibrium after 12 days with P. aeruginosa dominant; in a mouse chronic wound model, a four-species biofilm delayed healing only at 8 days post-infection and showed increased antimicrobial tolerance.
- P. aeruginosa produces multiple anti-staphylococcal molecules: HQNO and pyocyanin inhibit oxidative respiration and select for the SCV phenotype; LasA protease/staphylolysin lyses S. aureus; rhamnolipids and cis-2-decenoic acid induce biofilm dispersal and inhibit adhesion; long-chain AHLs (C8–C14, with C12 and C14 most effective) inhibit S. aureus growth and reduce sarA/agr function.
- S. aureus counter-strategies include the SigB-dependent SCV switch, which increases aminoglycoside resistance, biofilm formation, and intracellular survival; secreted protein A (SpA) binds Psl and type IV pili and protects P. aeruginosa from phagocytosis; yayurea A and B from the S. intermedius group quorum-quench Gram-negative bacteria; and CydAB variants in non-pathogenic staphylococci confer resistance to pyocyanin.
- Host/commensal molecules modulate virulence: AI-2 upregulates P. aeruginosa lasB, rhlA, exoT/exoS/exoY, and phzA1/phzA2; GlcNAc enhances PQS and virulence; D-ribose treatment significantly decreased biomass and lowered rat mortality in a dual-species ventilation model.
Methods
- Narrative review; no primary experiments. It synthesizes in vivo human/animal observations and in vitro studies on P. aeruginosa and Staphylococcus spp., primarily S. aureus.
- Main analysis is a qualitative synthesis of cited literature, organized by in vivo outcomes, P. aeruginosa virulence factors, S. aureus survival/SCV biology, dual-species biofilms, and other staphylococci. No systematic search, meta-analysis, or primary sample is described.
Limitations
- The paper states that interactions are strain- and environment-specific, that extracellular matrix components are largely underexplored, and that discrepancies between studies (e.g., Psl/S. aureus co-culture results, pigment production) indicate the importance of co-evolution and adaptation; further studies are awaited.
- Evident from the text: as a narrative review, it lacks a described systematic search or quality appraisal and relies on heterogeneous models, strains, and conditions, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 0 Not valid · 127 Not checked · 30 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic wounds are another example of biofilm-related infections wherein co-presence of P. aeruginosa and S. aureus has been shown to result in delayed wound healing compared to single species infections (Dalton et al., 2011; Seth et al., 2012; Pastar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Partly supportedcites Dalton et al., 2011 sourceExperimental — accuracy not yet measured
In the Results section 'Examining the ability of polymicrobial infections to promote wound chronicity', Dalton et al. do report that wounds with polymicrobial infections closed more slowly than monospecies infections, significant only at the 8-day time point (p<0.05) — but the comparison is a four-species biofilm (S. aureus, P. aeruginosa, E. faecalis, F. magna) versus P. aeruginosa alone in murine surgical excision wounds, not a P. aeruginosa/S. aureus co-presence comparison and not human chronic wounds. The same passage explicitly concludes that 'the mere presence of multiple species in a wound do not necessarily delay wound closure,' and the Discussion frames the finding as limited to one time point, so the claim's unqualified two-species causal statement overstates and re-specifies what this source shows. Part of what is attributed (delayed closure with polymicrobial, Pa-containing infections relative to single-species) is in the paper; the dual-species Pa+Sa attribution, the chronic-wound setting, and the general 'results in' framing are not. (LLM, conf=0.78)
- Not checked yetcites Seth et al., 2012 source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites Pastar et al., 2013 sourceExperimental — accuracy not yet measured
The Results section ('Mixed-species Infection Delays Epithelialization through Suppression of KGF1') and the Abstract state that simultaneous USA300 + P. aeruginosa infection significantly impaired epithelialization relative to single-species biofilms (day 2 rates 35% vs 42% and 57%, and 74% in uninfected controls), so the comparative core of the claim is supported. However, this was demonstrated in an acute porcine partial-thickness wound model, not in chronic wounds; the paper only notes in the Introduction/Discussion that chronic non-healing wounds are polymicrobial and that S. aureus and P. aeruginosa are prevalent there. The setting qualifier 'in chronic wounds' is therefore not supported by this source. (LLM, conf=0.80)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, polymicrobial infections showed increased antimicrobial tolerance compared to single species infection with P. aeruginosa in this study (Dalton et al., 2011).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Supportedcites Dalton et al., 2011 source
The Results section 'Measuring the antimicrobial tolerance of mono versus polymicrobial infections in situ' states that higher numbers of bacteria remained viable after bleach (2.3-fold) and gentamicin (3-fold) treatment in the polymicrobial infection group than in the P. aeruginosa monospecies group (Fig. 7A), and the Discussion repeats 'a higher level of antimicrobial tolerance from the bacteria making up the polymicrobial infection'. The Materials and Methods ('Chronically-wounded mouse model', 'Determining antimicrobial tolerance') confirm this was done in the murine chronic excision wound model, so population, comparator and direction of effect all match the paraphrase. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Not checked yetcites Harrison, 2007 source
- Not matchedcites Cystic Fibrosis Foundation, 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Nonetheless, recent studies have also co-isolated P. aeruginosa and Gram-positive bacteria, including S. aureus, from the same infection site where increased virulence and/or antibiotic resistance is described (Duan et al., 2003; Kirketerp-Moller et al., 2008; Fazli et al., 2009; Dalton et al., 2011; Korgaonkar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Introduction
What the sources say
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
79 more claims
Create a free account to see all 159 claims and to verify the 164 references still open.
- It may state two separate claims as one. 70
- Probably not a substantial claim. 8
Citations
Cites
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
What drives bacteria to produce a biofilm?
Jefferson, K. K. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.06.005 · Cited by 1,059
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
agr-Mediated Dispersal of Staphylococcus aureus Biofilms
Boles, B. R., & Horswill, A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000052 · Cited by 963
Williams, P., & Cámara, M. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.01.005 · Cited by 793
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Quorum Sensing and Bacterial Social Interactions in Biofilms
Li, Y.-H., & Tian, X. (2012) · Sensors · doi:10.3390/s120302519 · Cited by 694
Cited by
Items 101–200 of 289
Can multi-species biofilms defeat antimicrobial surfaces on medical devices?
Ramstedt, M., & Burmølle, M. (2022) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2022.100370 · Cited by 24
Niggli, S., Schwyter, L., Poveda, L., Grossmann, J., & Kümmerli, R. (2023) · mBio · doi:10.1128/mbio.03153-22 · Cited by 22
Silva, E., Monteiro, R., Grainha, T., Alves, D. F., Pereira, M. O., & Sousa, A. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00441 · Cited by 21
Dehbashi, S., Alikhani, M. Y., Tahmasebi, H., & Arabestani, M. R. (2021) · AMB Express · doi:10.1186/s13568-021-01210-y · Cited by 21
Scaffo, J. C., Lima, R. D., Dobrotka, C. J., Ribeiro, T. A. N., Pereira, R. F. A., Sachs, D., Ferreira, R. B. R., & Aguiar-Alves, F. (2025) · Antibiotics · doi:10.3390/antibiotics14050504 · Cited by 20
Gounani, Z., Karaman, D. Ş., Venu, A. P., Cheng, F., & Rosenholm, J. M. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.105994 · Cited by 20
Monych, N. K., & Turner, R. J. (2020) · mSystems · doi:10.1128/msystems.00746-20 · Cited by 20
Goff, M. L., Vastel, M., Lebrun, R., Mansuelle, P., Diarra, A., Grandjean, T., Triponney, P., Imbert, G., Gosset, P., Dessein, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859181 · Cited by 20
Genito, C. J., Darwitz, B. P., Greenwald, M. A., Wolfgang, M. C., & Thurlow, L. R. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02299-23 · Cited by 20
Ding, X., Masselot, C. R., Fu, X., Léonard, R., Marsac, B., Dauriat, C. J. G., Lepissier, A., Rytter, H., Ramond, E., Dupuis, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43863-2 · Cited by 20
Aptamer-based therapy for fighting biofilm-associated infections.
Sousa, A., Ferreira, D., Rodrigues, L. R., & Pereira, M. O. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.061 · Cited by 16
Phalak, P., & Henson, M. A. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14421 · Cited by 21
Keim, K. C., Bhattacharya, M., Crosby, H. A., Jenul, C., Mills, K. B., Schurr, M. J., & Horswill, A. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621402 · Cited by 24
Repurposing Farnesol for Combating Drug-Resistant and Persistent Single and Polymicrobial Biofilms
Tan, L., Ma, R., Reeves, T. E., Katz, A. J., & Levi, N. (2024) · Antibiotics · doi:10.3390/antibiotics13040350 · Cited by 20
Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?
Hurley, M. N., & Smyth, A. R. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000518 · Cited by 19
Montagut, E. J., & Marco, M. ‐. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03356-x · Cited by 19
The Clinical Significance of Staphylococcus aureus Small Colony Variants
Keim, K. C., George, I. K., Reynolds, L., & Smith, A. C. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac101 · Cited by 18
Khare, A. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.012 · Cited by 18
Montagut, E. J., Martín-Gómez, M. T., & Marco, M. ‐. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04731 · Cited by 17
Niggli, S., Wechsler, T., & Kümmerli, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.733991 · Cited by 17
Microbiota and fungal-bacterial interactions in the cystic fibrosis lung
Santos-Fernandez, E., Martin–Souto, L., Antoran, A., Areitio, M., Aparicio-Fernandez, L., Bouchara, J., Schwarz, C., Rementería, A., Buldain, I., & Ramirez‐Garcia, A. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad029 · Cited by 17
Montagut, E. J., Vilaplana, L., Martín-Gómez, M. T., & Marco, M. ‐. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00604 · Cited by 16
Contribution to determination of extracellular DNA origin in the biofilm matrix
Švarcová, V., Zdeňková, K., Boháčová, M., Demnerová, K., & Pazlarová, J. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100090 · Cited by 16
Molecular Mechanisms of Antimicrobial Resistance in Staphylococcus aureus Biofilms
SILVA, V. Y. N. E. D., Capelo, J. L., Igrejas, G., & Poeta, P. A. C. Q. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-84126-3_12 · Cited by 16
Borrelia and Chlamydia can form mixed biofilms in infected human skin tissues
Sapi, E., Gupta, K., Wawrzeniak, K., Gaur, G., Torres, J. P., Filush, K. R., Melillo, A., & Zelger, B. W. H. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00003 · Cited by 16
Robertson, S. N., Romero, M., Fenn, S. J., Riedi, P. L. K., & Cámara, M. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae042 · Cited by 15
Gong, F., Xin, S., Liu, X., He, C., Yu, X., Pan, L., Zhang, S., Gao, H., & Xu, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1445630 · Cited by 16
An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples
Hughes, D. A., Rosenthal, M., Cuthbertson, L., Ramadan, N. A., Felton, I. C., Simmonds, N. J., Loebinger, M. R., Price, H., Armstrong-James, D. P. H., Elborn, J. S., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.07.009 · Cited by 15
Dhekane, R., Mhade, S., & Kaushik, K. S. (2022) · Biofilm · doi:10.1016/j.bioflm.2022.100087 · Cited by 18
Sheykhsaran, E., Abbasi, A., Memar, M. Y., Ghotaslou, R., Baghi, H. B., Mazraeh, F. N., Laghousi, D., & Sadeghi, J. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116294 · Cited by 14
Chronic suppurative otitis media: disrupted host-microbial interactions and immune dysregulation
Yuan, V. G., Xia, A., & Maria, P. L. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547206 · Cited by 15
Martini, A. M., Alexander, S. A., & Khare, A. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011610 · Cited by 14
Zhao, K., Ma, J., Wang, X., Guo, Y., Yue, B., & Chu, Y. (2019) · Veterinary Microbiology · doi:10.1016/j.vetmic.2019.03.014 · Cited by 14
Fu, T., Cai, Z., Yue, Z., Yang, H., Fang, B., Zhang, X., Fan, Z., Pan, X., Yang, F. C., Jin, Y., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00837 · Cited by 14
An in vitro model for the cultivation of polymicrobial biofilms under continuous-flow conditions
O’Brien, T. J., Hassan, M. M., Harrison, F., & Welch, M. (2021) · F1000Research · doi:10.12688/f1000research.55140.1 · Cited by 14
Ran, M., Gounani, Z., Yan, J., Rosenholm, J. M., & Zhang, H. (2022) · Nano Select · doi:10.1002/nano.202200026 · Cited by 14
Yuan, Y., Li, J., Lin, J., Pan, W., Chu, Y., Prithiviraj, B., Guo, Y., Wang, X., & Zhao, K. (2020) · The Journal of Microbiology · doi:10.1007/s12275-021-0478-0 · Cited by 13
Microbial Interspecies Associations in Fracture-Related Infection
Gitajn, I. L., Werth, P. M., O’Toole, R. V., Joshi, M., Jevsevar, D. S., Wise, B. T., Rane, A., Horton, S. A., McClure, E. A., Ross, B. D., et al. (2021) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002314 · Cited by 13
Zhao, K., Li, J., Yang, X., Zeng, Q., Liu, W., Wu, Y., Zhou, H., Prithiviraj, B., Wang, X., Zhou, X., et al. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00592-22 · Cited by 13
Divergent Influence to a Pathogen Invader by Resident Bacteria with Different Social Interactions
Gao, C., Zhang, M., Wu, Y., Huang, Q., & Cai, P. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1207-z · Cited by 14
The mechanisms and cell signaling pathways of programmed cell death in the bacterial world
Smith, R. P., Barraza, I., Quinn, R. J., & Fortoul, M. C. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2019.12.002 · Cited by 13
The Sense and Nonsense of Antimicrobial Susceptibility Testing in Cystic Fibrosis
LiPuma, J. J. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac040 · Cited by 14
Martino, R. A., Volke, D. C., Tenaglia, A. H., Tribelli, P. M., Nikel, P. I., & Smania, A. M. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70137 · Cited by 13
Laffont, C., Wechsler, T., & Kümmerli, R. (2024) · Environmental Microbiology Reports · doi:10.1111/1758-2229.70015 · Cited by 13
Silver nanoparticles (AgNPs) in the control of Staphylococcus spp
da Cunha, K. F., de Albernaz, D. T. F., Garcia, M. O., Allend, S. O., & Hartwig, D. D. (2022) · Letters in Applied Microbiology · doi:10.1093/lambio/ovac032 · Cited by 12
Stari, L., Tusher, T. R., Inoue, C., & Chien, M.-F. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.137988 · Cited by 12
Truong, Q. C., Yonker, L. M., Wang, Y., Lawton, B., & Hooper, D. C. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-23 · Cited by 11
The exometabolome as a hidden driver of bacterial virulence and pathogenesis
Chugh, S., Létisse, F., & Neyrolles, O. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.11.009 · Cited by 11
Efficacy of a Ceratothoa oestroides Olive Oil Extract in Patients With Chronic Ulcers: A Pilot Study
Vitsos, A., Tsagarousianos, C., Vergos, O., Stithos, D., Mathioudakis, D., Vitsos, I., Zouni, P., Kakolyri, A., Meimeti, E., Kyriazi, M., et al. (2019) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734619856143 · Cited by 11
Lee, W. H., Oglesby, A. G., & Nolan, E. M. (2025) · mSystems · doi:10.1128/msystems.00576-25 · Cited by 10
Núñez-García, L. Á., Córdova‐Fletes, C., Barboza‐Cerda, M. C., & Garza‐González, E. (2026) · BioMed Research International · doi:10.1155/bmri/5328382 · Cited by 11
Antimicrobial Resistance and Biofilm Formation of Pseudomonas aeruginosa
Elmanama, A. A., Al-Sheboul, S. A., & Abu-Dan, R. I. (2020) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/846 · Cited by 12
Shumyatsky, G., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., Zemanick, E. T., & Hahn, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1082125 · Cited by 10
Matias, C. S. S., Serrano, I. D., van Harten, S., Mottola, C., Mendes, J. J., Tavares, L. M., & Oliveira, M. (2018) · Antonie van Leeuwenhoek · doi:10.1007/s10482-018-1103-z · Cited by 10
Nedelea, A., Plant, R. L., Robins, L. I., & Maddocks, S. E. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15239 · Cited by 10
Lee, S. M., Keum, H. L., & Sul, W. J. (2023) · The Journal of Microbiology · doi:10.1007/s12275-022-00002-8 · Cited by 10
Bautista-Hernández, L. A., Gómez‐Olivares, J. L., Buentello‐Volante, B., Domínguez-López, A., Garfias, Y., Acosta-García, M. C., Calvillo‐Medina, R. P., & Lucio, V. M. B. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103644 · Cited by 10
Antimicrobial resistance in chronic lung infection: the road to resistance
Kwok, W. C., Pates, K. M., Shah, A., Jackson, L., & Frost, F. J. (2025) · Thorax · doi:10.1136/thorax-2024-222396 · Cited by 9
Dynamics of bacterial biofilm development imaged using light sheet fluorescence microscopy
Šmerdová, L., Füzik, T., Valentová, L., Bárdy, P., Procházková, M., Pařenicová, M., & Plevka, P. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102127 · Cited by 9
Self-organized canals enable long-range directed material transport in bacterial communities
Li, Y., Liu, S., Zhang, Y., Seng, Z. J., Xu, H., Yang, L., & Wu, Y. (2022) · eLife · doi:10.7554/elife.79780 · Cited by 9
Pseudomonas aeruginosa : metabolic allies and adversaries in the world of polymicrobial infections
Sachdeva, C., Satyamoorthy, K., & Murali, T. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2397359 · Cited by 9
Pradhan, D., Tanwar, A., Wong, J. L. C., Parthasarathi, S., Frankel, G. M., & Singh, V. (2025) · mBio · doi:10.1128/mbio.01149-25 · Cited by 9
Li, J., Chen, X., Lin, J., Yuan, Y., Huang, T. L., Du, L., Prithiviraj, B., Zhang, A., Wang, X., Chu, Y., et al. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15461 · Cited by 10
Jha, Y. (2023) · Journal of Plant Protection Research · doi:10.24425/jppr.2019.129746 · Cited by 9
Heterogeneity Governs 3D‐Cultures of Clinically Relevant Microbial Communities
Pacheco, D. P., Bertoglio, F., Butnarasu, C., Vargas, N. S., Guagliano, G., Ziccarelli, A., Vangosa, F. B., Ruzzi, V., Buzzaccaro, S., Piazza, R., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202306116 · Cited by 8
The great divide: rhamnolipids mediate separation between P. aeruginosa and S. aureus
Bru, J.-L., Kasallis, S. J., Chang, R., Zhuo, Q., Nguyen, J., Pham, P., Warren, E., Whiteson, K., Høyland‐Kroghsbo, N. M., Limoli, D. H., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1245874 · Cited by 8
Aykaç, A., & Akkaş, E. Ö. (2022) · Recent Patents on Nanotechnology · doi:10.2174/1872210516666220414103629 · Cited by 8
Somayaji, R., Ramos, K. J., & Hoffman, L. R. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201712-944ed · Cited by 8
Roberts, B., da Silva, A. C., Sloan, T., Penfold, C. N., Williams, P. M., Diggle, S. P., & Hardie, K. R. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002118 · Cited by 7
Montagut, E. J., Raya, J., Martín-Gómez, M. T., Vilaplana, L., Rodríguez-Urretavizcaya, B., & Marco, M. ‐. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01073-21 · Cited by 7
Trognon, J., Rima, M., Lajoie, B., Roques, C. G., & Garah, F. E. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100153 · Cited by 7
Wang, G., Wang, Y., Chen, Y., & Ma, F. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106525 · Cited by 7
Monteiro, R., Magalhães, A. P., Pereira, M. O., & Sousa, A. M. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0025 · Cited by 7
Moriano, A., Serra, D. O., Hoard, A., Montaña, S., Degrossi, J., Bonomo, R. A., Papp‐Wallace, K. M., & Ramirez, M. S. (2021) · Current Microbiology · doi:10.1007/s00284-021-02458-0 · Cited by 7
Wolter, D. J., & Ramsey, B. W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3077ed · Cited by 7
Barucha, A., Mauch, R. M., Duckstein, F., Zagoya, C., & Mainz, J. G. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2104249 · Cited by 6
Host niche-specific challenges hindering the treatment of polymicrobial infections
Black, C., & Wakeman, C. A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00142-25 · Cited by 6
Topical Probiotics in Diabetic Wound Healing: Emerging Therapeutic Strategies
Celo, E., Dama, A., Hasho, S., & Deda, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062826 · Cited by 6
Probing Interkingdom Signaling Molecules via Liquid Extraction Surface Analysis–Mass Spectrometry
Robertson, S. N., Soukarieh, F., White, T. M., Cámara, M., Romero, M., & Griffiths, R. L. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05703 · Cited by 6
Ungor, I., & Apidianakis, Y. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0155 · Cited by 6
Emily, J. B., Allcott, G. J., & Cox, J. A. G. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00060-5 · Cited by 6
Nandanwar, N., 岩谷, 綱., Gibson, J. E., & Neely, M. N. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1484510 · Cited by 6
Lee, W. H., Zygiel, E. M., Lee, C. H., Oglesby, A. G., & Nolan, E. M. (2025) · mBio · doi:10.1128/mbio.03846-24 · Cited by 6
McClure, E. A., Werth, P. M., Ross, B. D., & Gitajn, I. L. (2023) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.22.00315 · Cited by 6
Mahout, M., Carlson, R. P., Simon, L., & Pérès, S. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00360-6 · Cited by 6
Siroosi, M., & Jabalameli, F. (2024) · Current Microbiology · doi:10.1007/s00284-024-03799-2 · Cited by 5
Katharios-Lanwermeyer, S., Zarrella, T. M., Godsil, M., Severin, S., Casiano, A. E., Tai, C., & Khare, A. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513122123 · Cited by 5
Yamamoto, K., Kusada, H., Kamagata, Y., & Tamaki, H. (2021) · Microorganisms · doi:10.3390/microorganisms9030569 · Cited by 5
Tanimu, H., Vijayan, N. K., & Sukumaran, B. O. (2022) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2022.12.6.p198-206 · Cited by 5
Akhmetzhan, G., Olaifa, K. W., Kitching, M., Cahill, P. A., Pham, T. T., Ajunwa, O. M., & Marsili, E. (2022) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2022.110156 · Cited by 5
Hughes, D. A., Price, H. C. W., Rosenthal, M., & Davies, J. C. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3639le · Cited by 5
Michalet, S., Allard, P., Commun, C., Ngoc, V.-T. N., Nouwade, K., Gioia, B., Dijoux‐Franca, M., Wolfender, J., & Doléans-Jordheim, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-99467-7 · Cited by 5
Tan, L., Sutton, K., Murphy, S. V., & Levi, N. (2025) · Biofilm · doi:10.1016/j.bioflm.2025.100317 · Cited by 4
Beyond reductionism: the emerging holistic paradigm in indirect control of pathogen infection
Jang, S., Kim, D., Seo, H. W., & Ryu, C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1638634 · Cited by 4
Small-colony variants of Staphylococcus aureus: hidden threat in chronic and recurrent infections
Khaja, A. S. S., Moursi, S. A., Saleem, M., Alshurtan, K. S., Abboh, E. A. A., Alshammari, A. D., Almalaq, H. A., Alshammari, M. N., & Almarshedy, S. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04917-y · Cited by 4
Zhou, Q.-Q., & Wan, Y. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00283-25 · Cited by 4
Keller, S. B., LuTheryn, G., Gray, M. D., Lyons, B., Cleveland, R. O., Stride, E., & Coussios, C. C. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad7f1a · Cited by 4
Júnior, A. A. D. B., Crugeira, P. J. L., Barbosa, A. V., Costa, W. L. R., Cangussú, M. C. T., de Oliveira, S. C. P. S., de Mello, A. I. V., Pinheiro, A. L. B., & Monteiro, J. S. C. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04362-6 · Cited by 4
Antimicrobial Efficacy and Stability of an N-Chlorotaurine Gel for Chronic Wound Treatment
Thomas, Z. M., Staudinger, G. J., Hooper, S. E., Williams, J. F., & Robins, L. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178677 · Cited by 4
Román‐Rodríguez, F., Tyagi, N., Kim, J., Parker, D., & Boyd, J. M. (2025) · Journal of Bacteriology · doi:10.1128/jb.00101-25 · Cited by 4
Metadata
- Authors
- Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S.
- Affiliations
- University of Antwerp (BE)
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-03
- Volume
- 7
- Pages
- 106-106
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC5376567
- OpenAlex
- W2599504373
- Cited by
- 289
- References
- 85
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 31 · 2023: 39 · 2022: 44 · 2021: 41 · 2020: 35 · 2019: 23 · 2018: 19
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Fonds Wetenschappelijk Onderzoek (G.0513.12)
- IMI (115737-2)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- Pseudomonas aeruginosa, Staphylococcus aureus, interspecies interactions, co-infection, biofilm, small colony variants, phagocytosis inhibition, extracellular matrix, cystic fibrosis lung infection, wound infection, bacterial competition, commensal microbiota
- MeSH terms
- Animals, Disease Models, Animal, Humans, Pseudomonas aeruginosa, Staphylococcus aureus, Microbial Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.